- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
- 中期趋势：
下跌有所减缓，仍应保持谨慎。
- 长期趋势：
已有48家主力机构披露2025-12-31报告期持股数据，持仓量总计7.69亿股，占流通A股59.80%
- 波段诊断：
-
技术面诊股
诊断结果：5.4技术面打败了49%的股票
技术面评分前10的股票
近期的平均成本为5.20元。空头行情中，目前反弹趋势有所减缓，投资者可适当关注。
平均成本
近期的平均成本为5.20元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"5.20","date":1779164230,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑输大盘，跑赢行业平均水平。
[{"date":"2026.05.19","stock":"0.58","trade":"0.76","ind":"0.92"},{"date":"2026.05.18","stock":"-0.76","trade":"-1.28","ind":"-0.09"},{"date":"2026.05.15","stock":"-0.76","trade":"-1.25","ind":"-1.02"},{"date":"2026.05.14","stock":"-1.13","trade":"-1.63","ind":"-1.52"},{"date":"2026.05.13","stock":"-1.84","trade":"-0.53","ind":"0.67"},{"date":"2026.05.12","stock":"0.93","trade":"-1.06","ind":"-0.25"},{"date":"2026.05.11","stock":"0.56","trade":"1.08","ind":"1.08"},{"date":"2026.05.08","stock":"0.94","trade":"0.13","ind":"-0.00"},{"date":"2026.05.07","stock":"0.00","trade":"-0.63","ind":"0.48"},{"date":"2026.05.06","stock":"0.38","trade":"0.58","ind":"1.17"},{"date":"2026.04.30","stock":"-2.94","trade":"-0.43","ind":"0.11"},{"date":"2026.04.29","stock":"0.18","trade":"0.59","ind":"0.71"},{"date":"2026.04.28","stock":"0.00","trade":"-0.13","ind":"-0.19"},{"date":"2026.04.27","stock":"-1.81","trade":"-0.19","ind":"0.16"},{"date":"2026.04.24","stock":"-2.98","trade":"-1.06","ind":"-0.33"},{"date":"2026.04.23","stock":"0.00","trade":"-0.05","ind":"-0.32"},{"date":"2026.04.22","stock":"-1.89","trade":"-0.97","ind":"0.52"},{"date":"2026.04.21","stock":"0.52","trade":"-0.86","ind":"0.07"},{"date":"2026.04.20","stock":"-3.51","trade":"0.68","ind":"0.76"},{"date":"2026.04.17","stock":"-3.85","trade":"-1.76","ind":"-0.10"},{"date":"2026.04.16","stock":"-2.66","trade":"-1.22","ind":"0.70"}]
南京医药,上证指数,医药商业指数
压力支撑
该股压力位为5.20元，支撑位为5.16元。
[{"text":"\u538b\u529b\u4f4d","value":"5.20","date":1779120000,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"5.16","date":1779120000,"color":"0x0b52a1"}]
多空趋势
空头行情中，目前反弹趋势有所减缓，投资者可适当关注。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：3.2资金面打败了40%的股票
主力控盘前10的股票
行业资金
医药商业行业， 近5日资金流出较多，不建议投资者关注该行业的个股。
更新时间：05月20日 12:49
| 机构今日流向(万元) | -1677.26 | 机构5日流向(万元) | -8858.21 |
| 机构10日流向(万元) | -12189.13 | 机构20日流向(万元) | -29980.17 |
机构持仓
2025-12-31 与 2025-06-30 相比，主力机构持仓量减少2375.86万股，其中基金净减仓1家，主力净减仓74家，请投资者中长期谨慎为宜。
截止2025-12-31，共48家主力机构（基金44家，一般法人4家），持仓量总计76861.8万股，占流通A股59.80%
其中，基金持仓与2025-06-30相比：
增仓：10家 ，增持 72.67万股
减仓：11家 ，减持 27.19万股
新出现在主力名单中：21家 ，持有153.94万股
从主力名单中消失：95家 ，原持有2640.21万股
其中，基金持仓与2025-06-30相比：
增仓：10家 ，增持 72.67万股
减仓：11家 ，减持 27.19万股
新出现在主力名单中：21家 ，持有153.94万股
从主力名单中消失：95家 ，原持有2640.21万股
消息面诊股
诊断结果：5.6消息面打败了42%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 南京医药获评“南京市2025年度市级总部企业（5A
2026-05-19 - 600713突发！终止投资
2026-05-19 - 南京医药：终止投资宁波江丰生物信息技术有限公司
2026-05-19 - 南京医药：公司市值管理工作已全面纳入公司战略规划并
2026-05-19 - 行业周报|医药商业指数跌-3.37%, 跑输上证指
2026-05-15 - 南京又跑出百亿药企IPO，初始投资人竟是浦口地产商
2026-05-13 - 医保即时结算改革落地见效 头部医药企业现金流改善明
2026-05-12 - 南京医药：积极推进数字化转型
2026-05-11 - 南京医药：注册资本将减少至约13.08亿元
2026-05-12 - 国控、上药、华润医药、九州通等头部商业一季报亮点解
2026-05-09
消息列表
| 一般消息 | 募资投向 | 公司购买资产 | 2026-05-20 |
| 一般消息 | 重大事项 | 关联交易 | 2026-05-09 |
| 一般消息 | 股东大会 | 年度股东大会 | 2026-04-30 |
| 一般消息 | 募资投向 | 公司出售资产 | 2026-04-30 |
| 一般消息 | 重大事项 | 关联交易 | 2026-04-30 |
| 利好 | 分红转增 | 10派1.7元(含税) | 2026-04-11 |
| 一般消息 | 重大事项 | 关联交易 | 2026-04-11 |
| 一般消息 | 募资投向 | 2026-04-10 | |
| 一般消息 | 高管变动 | 公司与Alliance Healt... | 2026-04-02 |
| 一般消息 | 重大事项 | 关联交易 | 2026-03-21 |
| 一般消息 | 重大事项 | 关联交易 | 2026-03-18 |
| 一般消息 | 高管变动 | 根据协议约定，解聘相关职务 | 2026-03-17 |
| 一般消息 | 资产重组 | 公司股权转让 | 2026-02-28 |
| 一般消息 | 重大事项 | 关联交易 | 2026-01-21 |
| 一般消息 | 高管变动 | 取消监事会 | 2025-11-19 |
| 一般消息 | 高管变动 | 因有其他工作安排 | 2025-10-17 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-30 |
| 一般消息 | 重大事项 | 关联交易 | 2025-08-30 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 1条 | 0条 | 1条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：5.2行业面打败了70%的股票
医药商业行业最新资金流向
近10日来该行业走势不明显，明显跑输大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，明显跑输大盘。
[{"date":"2026.05.19","price":"0.92","value":"0.76"},{"date":"2026.05.18","price":"-0.09","value":"-1.28"},{"date":"2026.05.15","price":"-1.02","value":"-1.25"},{"date":"2026.05.14","price":"-1.52","value":"-1.63"},{"date":"2026.05.13","price":"0.67","value":"-0.53"},{"date":"2026.05.12","price":"-0.25","value":"-1.06"},{"date":"2026.05.11","price":"1.08","value":"1.08"},{"date":"2026.05.08","price":"-0.00","value":"0.13"},{"date":"2026.05.07","price":"0.48","value":"-0.63"},{"date":"2026.05.06","price":"1.17","value":"0.58"},{"date":"2026.04.30","price":"0.11","value":"-0.43"},{"date":"2026.04.29","price":"0.71","value":"0.59"},{"date":"2026.04.28","price":"-0.19","value":"-0.13"},{"date":"2026.04.27","price":"0.16","value":"-0.19"},{"date":"2026.04.24","price":"-0.33","value":"-1.06"},{"date":"2026.04.23","price":"-0.32","value":"-0.05"},{"date":"2026.04.22","price":"0.52","value":"-0.97"},{"date":"2026.04.21","price":"0.07","value":"-0.86"},{"date":"2026.04.20","price":"0.76","value":"0.68"},{"date":"2026.04.17","price":"-0.10","value":"-1.76"},{"date":"2026.04.16","price":"0.70","value":"-1.22"}]
上证指数,医药商业行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 润达医疗 | 16.64% | 12.63% | 5.4分 |
| 2 | 英特集团 | 7.37% | 3.65% | 6.0分 |
| 3 | 重药控股 | 6.89% | -4.26% | 6.1分 |
| 4 | 达嘉维康 | 3.68% | -1.99% | 5.2分 |
| 5 | 健之佳 | 1.73% | -2.21% | 4.9分 |
| 6 | 大参林 | 1.54% | -5.17% | 5.3分 |
| 8 | 开开实业 | -0.88% | -2.37% | 5.2分 |
| 10 | 上海医药 | -2.39% | -2.45% | 4.8分 |
| 12 | 柳药集团 | -3.75% | -2.43% | 4.6分 |
| 14 | 国科恒泰 | -5.60% | -4.79% | 4.1分 |
| 16 | 老百姓 | -6.89% | -5.24% | 4.6分 |
| 18 | 九州通 | -7.87% | -2.96% | 4.9分 |
| 20 | 国药一致 | -8.90% | -1.99% | 4.4分 |
| 22 | 建发致新 | -10.18% | -3.93% | 5.1分 |
| 24 | 漱玉平民 | -12.53% | -2.30% | 5.0分 |
| 26 | 百洋医药 | -14.61% | -5.96% | 4.3分 |
| 28 | 药易购 | -15.39% | -2.58% | 3.6分 |
| 30 | 南京医药 | -16.21% | -3.87% | 5.0分 |
| 32 | ST海王 | -52.74% | -22.76% | 4.8分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2026-03-31 ]公司经营
盈利能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 10/70 ， 30/70。
[{"date":"2026-03-31","value":"2.40","vol":"1.69"},{"date":"2025-12-31","value":"8.91","vol":"3.13"},{"date":"2025-09-30","value":"5.82","vol":"4.89"},{"date":"2025-06-30","value":"4.25","vol":"3.26"},{"date":"2025-03-31","value":"2.56","vol":"1.75"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
2.40 | 8.91 | 5.82 | 4.25 | 2.56 |
| 行业(%) | 1.69 | 3.13 | 4.89 | 3.26 | 1.75 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"6.28","vol":"17.52"},{"date":"2025-12-31","value":"6.15","vol":"17.30"},{"date":"2025-09-30","value":"5.95","vol":"17.32"},{"date":"2025-06-30","value":"5.91","vol":"17.29"},{"date":"2025-03-31","value":"5.96","vol":"17.36"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
6.28 | 6.15 | 5.95 | 5.91 | 5.96 |
| 行业(%) | 17.52 | 17.30 | 17.32 | 17.29 | 17.36 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 20/70 ， 19/70。
[{"date":"2026-03-31","value":"-2.83","vol":"-3.73"},{"date":"2025-12-31","value":"2.36","vol":"-3.19"},{"date":"2025-09-30","value":"0.48","vol":"-3.13"},{"date":"2025-06-30","value":"2.70","vol":"-3.59"},{"date":"2025-03-31","value":"2.11","vol":"-4.22"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-2.83 | 2.36 | 0.48 | 2.70 | 2.11 |
| 行业(%) | -3.73 | -3.19 | -3.13 | -3.59 | -4.22 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"-1.57","vol":"11.07"},{"date":"2025-12-31","value":"9.50","vol":"-71.43"},{"date":"2025-09-30","value":"-9.03","vol":"-5.36"},{"date":"2025-06-30","value":"-6.44","vol":"-58.56"},{"date":"2025-03-31","value":"11.49","vol":"-44.86"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-1.57 | 9.50 | -9.03 | -6.44 | 11.49 |
| 行业(%) | 11.07 | -71.43 | -5.36 | -58.56 | -44.86 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 3/70 ， 8/70。
[{"date":"2026-03-31","value":"0.41","vol":"0.28"},{"date":"2025-12-31","value":"1.77","vol":"1.15"},{"date":"2025-09-30","value":"1.27","vol":"0.85"},{"date":"2025-06-30","value":"0.88","vol":"0.57"},{"date":"2025-03-31","value":"0.44","vol":"0.29"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.41 | 1.77 | 1.27 | 0.88 | 0.44 |
| 行业(次) | 0.28 | 1.15 | 0.85 | 0.57 | 0.29 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"1.85","vol":"1.37"},{"date":"2025-12-31","value":"7.82","vol":"5.73"},{"date":"2025-09-30","value":"6.00","vol":"4.30"},{"date":"2025-06-30","value":"4.23","vol":"2.88"},{"date":"2025-03-31","value":"2.13","vol":"1.42"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
1.85 | 7.82 | 6.00 | 4.23 | 2.13 |
| 行业(次) | 1.37 | 5.73 | 4.30 | 2.88 | 1.42 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2026-03-31","value":"-37.52","vol":"-3.40"},{"date":"2025-12-31","value":"36.65","vol":"9.78"},{"date":"2025-09-30","value":"-7.18","vol":"4.37"},{"date":"2025-06-30","value":"-3.14","vol":"6.90"},{"date":"2025-03-31","value":"-25.27","vol":"0.70"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | -37.52 | 36.65 | -7.18 | -3.14 | -25.27 |
| 行业 | -3.40 | 9.78 | 4.37 | 6.90 | 0.70 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"0.83","vol":"0.58"},{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"0.94","vol":"0.54"},{"date":"2025-03-31","value":"","vol":"0.00"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 0.83 | - | 0.94 | - |
| 行业 | 0.00 | 0.58 | 0.00 | 0.54 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 13/70 ， 8/70。
[{"date":"2026-03-31","value":"1.45","vol":"1.41"},{"date":"2025-12-31","value":"1.53","vol":"1.39"},{"date":"2025-09-30","value":"1.45","vol":"1.42"},{"date":"2025-06-30","value":"1.46","vol":"1.41"},{"date":"2025-03-31","value":"1.55","vol":"1.44"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 流动比率 |
1.45 | 1.53 | 1.45 | 1.46 | 1.55 |
| 行业 | 1.41 | 1.39 | 1.42 | 1.41 | 1.44 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"1.08","vol":"0.99"},{"date":"2025-12-31","value":"1.10","vol":"0.97"},{"date":"2025-09-30","value":"1.08","vol":"0.99"},{"date":"2025-06-30","value":"1.11","vol":"0.99"},{"date":"2025-03-31","value":"1.18","vol":"1.01"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 速动比率 |
1.08 | 1.10 | 1.08 | 1.11 | 1.18 |
| 行业 | 0.99 | 0.97 | 0.99 | 0.99 | 1.01 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 29/70 ， 4/70。
[{"date":"2026-03-31","value":"76.16","vol":"60.81"},{"date":"2025-12-31","value":"73.74","vol":"61.28"},{"date":"2025-09-30","value":"76.62","vol":"61.47"},{"date":"2025-06-30","value":"76.35","vol":"62.27"},{"date":"2025-03-31","value":"76.09","vol":"61.71"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
76.16 | 73.74 | 76.62 | 76.35 | 76.09 |
| 行业(%) | 60.81 | 61.28 | 61.47 | 62.27 | 61.71 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"3.68","vol":"2.53"},{"date":"2025-12-31","value":"3.23","vol":"2.56"},{"date":"2025-09-30","value":"3.74","vol":"2.39"},{"date":"2025-06-30","value":"3.70","vol":"2.48"},{"date":"2025-03-31","value":"3.63","vol":"2.47"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
3.68 | 3.23 | 3.74 | 3.70 | 3.63 |
| 行业(%) | 2.53 | 2.56 | 2.39 | 2.48 | 2.47 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
暂时还没有机构预测该股2026年的收益，请投资者后续关注。
[{"date":"2022","yellowRectValue":"5.96","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"5.78","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"5.71","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"6.25","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]